Big Blog

Arts & Culture
Biological Science
Blog Watch
Computer Games
Computer Security
Cricket
Data Privacy
Developer
Domain Names
E-commerce
Gadgets
General Science
Handhelds
IP & Patents
Java
Linux
MP3
Nanotech
Online Auctions
Online Legal Issues
Open Source
Personal Finance
Photography
Quirky
Robotics
Search Engines
Space Science
Top Internet
Top Stories
Top Tech
Video Games
Web Developer
Webmaster Tips
XML & Metadata
{Home}



Steno Superbug Genome Shows Extreme Drug Resistance: related news

Superbug genome sequenced

Add our medical news to digg - Superbug genome sequenced Add our medical news to NewsVine - Superbug genome sequenced Add our medical news to Fark - Superbug genome sequenced Add our medical news to Furl - Superbug genome sequenced Add our medical news to Shadows - Superbug genome sequenced Add our medical news to YahooMyWeb - Superbug genome sequenced Add our medical news to Reddit -Superbug genome sequenced Add our medical news to StumbleUpon - Superbug genome sequenced Add our medical news to Facebook - Superbug genome sequenced

Steno 'Superbug' Genome Shows Extreme Drug Resistance

home > infectious disease center > infectious disease a-z list > steno 'superbug' genome shows drug resistance article

Superbug Genome Sequenced: Steno Has Remarkable Capacity For Drug Resistance

The genome of a newly-emerging superbug, commonly known as Steno, has just been sequenced. The results reveal an organism with a remarkable capacity for drug resistance. The research was carried out by scientists at the Wellcome Trust Sanger Institute near Cambridge and the University of Bristol.

Steno 'Superbug' Genome Shows Extreme Drug Resistance

Home | Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker

Steno 'Superbug' Genome Shows Extreme Drug Resistance

Home Business Tech Markets Entrepreneurs Leadership Personal Finance ForbesLife Lists Opinions Video Blogs E-mail Newsletters People Tracker Portfolio Tracker Special Reports Commerce Energy Health Care Logistics Manufacturing Media Services Technology Wall Street Washington CIO Network Enterprise Tech Infoimaging Internet Infrastructure Internet Personal Tech Sciences Security Wireless Bonds Commodities Currencies Economy Emerging Markets Equities Options Finance Human Resources Law & Taxation Sales & Marketing Management Technology Careers Compensation Corporate Citizenship Corporate Governance Managing Innovation CEO Network Reference ETFs Guru Insights Investing Ideas Investor Education Mutual Funds Philanthropy Retirement & College Taxes & Estates Collecting Health Real Estate Sports Style Travel Vehicles Wine & Food 100 Top Celebrit

Drug information for the iPhone

Add our medical news to digg - Drug information for the iPhone Add our medical news to NewsVine - Drug information for the iPhone Add our medical news to Fark - Drug information for the iPhone Add our medical news to Furl - Drug information for the iPhone Add our medical news to Shadows - Drug information for the iPhone Add our medical news to YahooMyWeb - Drug information for the iPhone Add our medical news to Reddit -Drug information for the iPhone Add our medical news to StumbleUpon - Drug information for the iPhone Add our medical news to Facebook - Drug information for the iPhone

New chemicals shield 'genome guardian'

Add our medical news to digg - New chemicals shield 'genome guardian' Add our medical news to NewsVine - New chemicals shield 'genome guardian' Add our medical news to Fark - New chemicals shield 'genome guardian' Add our medical news to Furl - New chemicals shield 'genome guardian' Add our medical news to Shadows - New chemicals shield 'genome guardian' Add our medical news to YahooMyWeb - New chemicals shield 'genome guardian' Add our medical news to Reddit -New chemicals shield 'genome guardian' Add our medical news to StumbleUpon - New chemicals shield 'genome guardian' Add our medical news to Facebook - New chemicals shield 'genome guardian'

Superbug Genome Sequenced

The genome of a newly-emerging superbug, commonly known as Steno, has just been sequenced. The results reveal an organism with a remarkable capacity for drug resistance. The research was carried out by scientists at the Wellcome Trust Sanger Institute near Cambridge and the University of Bristol. Understanding the genome of this bacterium will help researchers discover how to deal with this particularly resistant organism. The paper will be published in Genome Biology.

Steno superbug genome sequenced

The genome of a newly emerging superbug, commonly known as Steno, reveals an organism with a remarkable capacity for drug resistance.

Superbug genome sequenced

The genome of a newly emerging superbug, commonly known as Steno, reveals an organism with a remarkable capacity for drug resistance

Superbug genome sequenced

The genome of a newly emerging superbug, commonly known as Steno, reveals an organism with a remarkable capacity for drug resistance

Superbug genome sequenced

The genome of a newly-emerging superbug, commonly known as Steno, has just been sequenced. The results reveal an organism with a remarkable capacity for drug resistance. The research was carried out by scientists at the Wellcome Trust Sanger Institute near Cambridge and the University of Bristol.

Superbug genome sequenced

The genome of a newly-emerging superbug, commonly known as Steno, has just been sequenced. The results reveal an organism with a remarkable capacity for drug resistance.

First Draft of Oil Palm Genome Completed by Synthetic Genomics Inc and Asiatic Centre for Genome Technology

KUALA LUMPUR, Malaysia and LA JOLLA, Calif., May 21 /PRNewswire/ -- Asiatic Centre for Genome Technology Sdn Bhd (ACGT), which is focused on the commercial application of genome technology to improve oil palm and other crops and Synthetic Genomics Inc. (SGI), a privately held company dedicated to commercializing genomic-driven solutions to address global energy and environmental challenges, today announced the completion of a first draft assembly and annotation of the oil palm genome. The organizations also announced that they have made progress in sequencing and analyzing the jatropha genome. The oil palm and jatropha genome projects represent the first stages of research undertaken through a joint venture between SGI and ACGT which was announced in 2007 and is aimed at developing more high-yielding and disease-resistant plant feedstocks

Steno 'Superbug' Genome Shows Extreme D...

Enter your 5-digit ZIP code for a summary of dental plans available in your area, complete with dental savings information and nearby participating dentists.

Mindpix Announces Patent Pending 'Multi-Resistance' Product: UltraFlex(TM)

Mindpix Corporation, a Nevada Corporation (PINKSHEETS: MPIX), is pleased to announce that Mindpix, Inc. (http://www.mindpix.com) has developed a vastly improved product using a proprietary "multi-resistance" technology. The patent pending product will keep the same name as its predecessor for branding purposes. Older versions will not be sold. UltraFlex(TM) new 'multi-resistance' device provides a unique form of resistance training. Multi-resistance is achieved by moving the hand position higher on the clearly indicated UltraFlex(TM) grip, increasing the resistance by as much as 25%. This creates a product that will challenge and grow with users when they desire or are able to do more advanced exercise moves. The exercise resistance is increased or decreased through range-of-motion adjustments, by changing hand position on the device, or

Mindpix Announces Patent Pending 'Multi-Resistance' Product:

Mindpix Corporation, a Nevada Corporation (PINKSHEETS: MPIX), is pleased to announce that Mindpix, Inc. (http://www.mindpix.com) has developed a vastly improved product using a proprietary "multi-resistance" technology. The patent pending product will keep the same name as its predecessor for branding purposes. Older versions will not be sold. UltraFlex(TM) new 'multi-resistance' device provides a unique form of resistance training. Multi-resistance is achieved by moving the hand position higher on the clearly indicated UltraFlex(TM) grip, increasing the resistance by as much as 25%. This creates a product that will challenge and grow with users when they desire or are able to do more advanced exercise moves. The exercise resistance is increased or decreased through range-of-motion adjustments, by changing hand position on the device, or

Mindpix Announces Patent Pending 'Multi-Resistance' Product: UltraFlex(TM)

OREM, UT -- (MARKET WIRE) -- 05/28/08 -- Mindpix Corporation, a Nevada Corporation (MPIX), is pleased to announce that Mindpix, Inc. (http://www.mindpix.com) has developed a vastly improved product using a proprietary "multi-resistance" technology. The patent pending product will keep the same name as its predecessor for branding purposes. Older versions will not be sold. UltraFlex(TM) new 'multi-resistance' device provides a unique form of resistance training. Multi-resistance is achieved by moving the hand position higher on the clearly indicated UltraFlex(TM) grip, increasing the resistance by as much as 25%. This creates a product that will challenge and grow with users when they desire or are able to do more advanced exercise moves. The exercise resistance is increased or decreased through range-of-motion adjustments, by changing han

First sequence-based map of large-scale structural variation across the human genome

Add our medical news to Google Add our medical news to del.icio.us - First sequence-based map of large-scale structural variation across the human genome Add our medical news to digg - First sequence-based map of large-scale structural variation across the human genome Add our medical news to NewsVine - First sequence-based map of large-scale structural variation across the human genome Add our medical news to Fark - First sequence-based map of large-scale structural variation across the human genome Add our medical news to Furl - First sequence-based map of large-scale structural variation across the human genome Add our medical news to Shadows - First sequence-based map of large-scale structural variation across the human genome Add our medical news to YahooMyWeb - First sequence-based map of large-scale structural variation across the

Platypus genome unravels mysteries of mammalian evolution

Genome Research is publishing several papers related to analyses of the duck-billed platypus (Ornithorhynchus anatinus) genome sequence. The place of (egg-laying) monotremes, such as the platypus, in mammalian evolutionary history has remained controversial. Now, researchers are finding that the distinctive anatomical and physiological properties of the platypus are reflected in the newly sequenced platypus genome. Through comparative genomics, the platypus genome is providing remarkable insights into the evolution of venom components, the sex-determination system, testicular descent, and small RNA pathways. Primary research reports describing these novel insights will appear online May 8, concurrent with publication of the platypus genome sequence report in the journal Nature.

Mindpix Announces Patent Pending 'Multi-Resistance' Product: UltraFlex(TM)

OREM, UT--(MARKET WIRE)--May 28, 2008 -- Mindpix Corporation, a Nevada Corporation (Other OTC:MPIX.PK - News), is pleased to announce that Mindpix, Inc. (http://www.mindpix.com) has developed a vastly improved product using a proprietary "multi-resistance" technology. The patent pending product will keep the same name as its predecessor for branding purposes. Older versions will not be sold. UltraFlex(TM) new 'multi-resistance' device provides a unique form of resistance training. Multi-resistance is achieved by moving the hand position higher on the clearly indicated UltraFlex(TM) grip, increasing the resistance by as much as 25%. This creates a product that will challenge and grow with users when they desire or are able to do more advanced exercise moves.

Mindpix Announces Patent Pending 'Multi-Resistance' Product: UltraFlex(TM)

OREM, UT -- (MARKET WIRE) -- 05/28/08 -- Mindpix Corporation, a Nevada Corporation (PINKSHEETS: MPIX), is pleased to announce that Mindpix, Inc. (http://www.mindpix.com) has developed a vastly improved product using a proprietary "multi-resistance" technology. The patent pending product will keep the same name as its predecessor for branding purposes. Older versions will not be sold. UltraFlex(TM) new 'multi-resistance' device provides a unique form of resistance training. Multi-resistance is achieved by moving the hand position higher on the clearly indicated UltraFlex(TM) grip, increasing the resistance by as much as 25%. This creates a product that will challenge and grow with users when they desire or are able to do more advanced exercise moves.

New Superbug Genome Sequenced

British medical scientists announced Wednesday they have sequenced the genome of a newly emerging superbug known as Steno.

New superbug genome sequenced

British medical scientists announced Wednesday they have sequenced the genome of a newly emerging superbug known as Steno.


Search News:


Copyright © 2001-2008 Jonathan Hedley